AAAAAA

   
Results: 1-16 |
Results: 16
GENETIC-ANALYSIS OF ADENOVIRUS E1A - INDUCTION OF GENETIC INSTABILITYAND ALTERED CELL MORPHOLOGIC AND GROWTH-CHARACTERISTICS ARE SEGREGATABLE FUNCTIONS
Authors: DREWS R KOLKER M MORAN C SACHAR D CHAN V SCHNIPPER L
Citation: R. Drews et al., GENETIC-ANALYSIS OF ADENOVIRUS E1A - INDUCTION OF GENETIC INSTABILITYAND ALTERED CELL MORPHOLOGIC AND GROWTH-CHARACTERISTICS ARE SEGREGATABLE FUNCTIONS, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 421(1), 1998, pp. 9-25
DOSE-ESCALATION OF THE HYPOXIC CELL SENSITIZER ETANIDAZOLE COMBINED WITH IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT
Authors: ELIAS AD WHEELER C AYASH LJ SCHWARTZ G IBRAHIM J MILLS L MCCAULEY M COLEMAN N WARREN D SCHNIPPER L ANTMAN KH TEICHER BA FREI E
Citation: Ad. Elias et al., DOSE-ESCALATION OF THE HYPOXIC CELL SENSITIZER ETANIDAZOLE COMBINED WITH IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT, Clinical cancer research, 4(6), 1998, pp. 1443-1449
CANCER CARE DURING THE LAST PHASE OF LIFE
Authors: SCHNIPPER L BITRAN JD BLANK LL BLUM D BROCK D BRUERA E EMANUEL EJ FOLEY KM GORDON DS HILDEN JM KAGAN RA LEVY MH LICHTER AS LINK MP PENLEY WC SMITH TJ STANLEY K STOVALL E TOKAZ LK WOOD WC MAYER R
Citation: L. Schnipper et al., CANCER CARE DURING THE LAST PHASE OF LIFE, Journal of clinical oncology, 16(5), 1998, pp. 1986-1996
HIGH-DOSE MULTIMODALITY THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FORSTAGE IIIB BREAST-CARCINOMA
Authors: AYASH LJ ELIAS A IBRAHIM J SCHWARTZ G WHEELER C REICH E LYNCH C WARREN D SHAPIRO C RICHARDSON P HURD D SCHNIPPER L FREI E ANTMAN K
Citation: Lj. Ayash et al., HIGH-DOSE MULTIMODALITY THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FORSTAGE IIIB BREAST-CARCINOMA, Journal of clinical oncology, 16(3), 1998, pp. 1000-1007
NEUTROPENIC ENTEROCOLITIS AS A COMPLICATION OF HIGH-DOSE CHEMOTHERAPYWITH STEM-CELL RESCUE IN PATIENTS WITH SOLID TUMORS - A CASE SERIES WITH A REVIEW OF THE LITERATURE
Authors: AVIGAN D RICHARDSON P ELIAS A DEMETRI G SHAPIRO M SCHNIPPER L WHEELER C
Citation: D. Avigan et al., NEUTROPENIC ENTEROCOLITIS AS A COMPLICATION OF HIGH-DOSE CHEMOTHERAPYWITH STEM-CELL RESCUE IN PATIENTS WITH SOLID TUMORS - A CASE SERIES WITH A REVIEW OF THE LITERATURE, Cancer, 83(3), 1998, pp. 409-414
DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR METASTATIC BREAST-CANCER - NO IMPROVEMENT IN PROGRESSION-FREE SURVIVAL BY THE SEQUENCE OF HIGH-DOSE MELPHALAN FOLLOWED BY CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN
Authors: AYASH LJ ELIAS A SCHWARTZ G WHEELER C IBRAHIM J TEICHER BA REICH E WARREN D LYNCH C RICHARDSON P SCHNIPPER L FREI E ANTMAN K
Citation: Lj. Ayash et al., DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR METASTATIC BREAST-CANCER - NO IMPROVEMENT IN PROGRESSION-FREE SURVIVAL BY THE SEQUENCE OF HIGH-DOSE MELPHALAN FOLLOWED BY CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN, Journal of clinical oncology, 14(11), 1996, pp. 2984-2992
PROGNOSTIC FACTORS FOR PROLONGED PROGRESSION-FREE SURVIVAL WITH HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR ADVANCED BREAST-CANCER
Authors: AYASH LJ WHEELER C FAIRCLOUGH D SCHWARTZ G REICH E WARREN D SCHNIPPER L ANTMAN K FREI E ELIAS A
Citation: Lj. Ayash et al., PROGNOSTIC FACTORS FOR PROLONGED PROGRESSION-FREE SURVIVAL WITH HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR ADVANCED BREAST-CANCER, Journal of clinical oncology, 13(8), 1995, pp. 2043-2049
PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT
Authors: ELIAS AD AYASH LJ WHEELER C SCHWARTZ G TEPLER I GONIN R MCCAULEY M MAZANET R SCHNIPPER L FREI E ANTMAN KH
Citation: Ad. Elias et al., PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT, Bone marrow transplantation, 15(3), 1995, pp. 373-379
THE COLLECTION AND EVALUATION OF PERIPHERAL-BLOOD PROGENITOR CELLS SUFFICIENT FOR REPETITIVE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORT
Authors: BENJAMIN RJ LINSLEY L AXELROD JD CHURCHILL WH SIEFF C SHULMAN LN ELIAS A AYASH L MALACHOWSKI ME UHL L GAYNES L MCCAULEY M THOMPSON L MAZANET R ANTMAN K SCHNIPPER L TEPLER I ANTIN JH WHEELER C
Citation: Rj. Benjamin et al., THE COLLECTION AND EVALUATION OF PERIPHERAL-BLOOD PROGENITOR CELLS SUFFICIENT FOR REPETITIVE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORT, Transfusion, 35(10), 1995, pp. 837-844
THE USE OF DEFIBROTIDE [DF] IN BMT-ASSOCIATED VENOOCCLUSIVE DISEASE [VOD]
Authors: RICHARDSON P KRISHMAN A WHEELER C AYASH L HOPPENSTEADT D FAREED J SCHNIPPER L KUFE D FREI E ELIAS A
Citation: P. Richardson et al., THE USE OF DEFIBROTIDE [DF] IN BMT-ASSOCIATED VENOOCCLUSIVE DISEASE [VOD], Blood, 86(10), 1995, pp. 870-870
DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR METASTATIC BREAST-CANCER - A FEASIBILITY STUDY
Authors: AYASH LJ ELIAS A WHEELER C REICH E SCHWARTZ G MAZANEF R TEPLER I WARREN D LYNCH C GONIN R SCHNIPPER L FREI E ANTMAN K
Citation: Lj. Ayash et al., DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR METASTATIC BREAST-CANCER - A FEASIBILITY STUDY, Journal of clinical oncology, 12(1), 1994, pp. 37-44
HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT - SAFETY AND FUTURE-DIRECTIONS/
Authors: ELIAS AD AYASH LJ WHEELER C SCHWARTZ G TEPLER I MCCAULEY M MAZANET R SCHNIPPER L FREI E ANTMAN KH
Citation: Ad. Elias et al., HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT - SAFETY AND FUTURE-DIRECTIONS/, Seminars in oncology, 21(5), 1994, pp. 83-85
EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION
Authors: TEPLER I ELIAS A KALISH L SHULMAN L STRAUSS G SKARIN A LYNCH T LEVITT D RESTA D DEMETRI G GAYNES L SCHNIPPER L
Citation: I. Tepler et al., EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION, British Journal of Haematology, 87(4), 1994, pp. 678-686
STRATEGIES FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR USE INHIGH-DOSE CHEMOTHERAPY
Authors: WEBB IJ AYASH LJ EICKHOFF CE WHEELER C SCHWARTZ G MAZANET R DEMETRI G ANTMAN K SCHNIPPER L FREI E ELIAS A
Citation: Ij. Webb et al., STRATEGIES FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR USE INHIGH-DOSE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000105-10000105
OUTPATIENT-BASED TREATMENT WITH MULTIPLE CYCLES OF DOSE-INTENSIFIED IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY SUPPORTED BY PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY G-CSF - EFFICIENTCOLLECTION OF PROGENITOR CELLS WITH RAPID HEMATOLOGIC RECOVERY
Authors: TEPLER I DEMETRI G MCCAULEY M GAYNES L HARVEY S SKARIN A STRAUSS G AYASH L WHEELER C SCHWARTZ G SCHNIPPER L FREI E ELIAS IA
Citation: I. Tepler et al., OUTPATIENT-BASED TREATMENT WITH MULTIPLE CYCLES OF DOSE-INTENSIFIED IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY SUPPORTED BY PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY G-CSF - EFFICIENTCOLLECTION OF PROGENITOR CELLS WITH RAPID HEMATOLOGIC RECOVERY, Blood, 84(10), 1994, pp. 10000211-10000211
SEQUENTIAL IFOSFAMIDE (I), CARBOPLATIN (C), AND ETOPOSIDE (E) WITH STEROIDS AND CYCLOPHOSPHAMIDE G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT (SPICE) IN RELAPSED LYMPHOMA/
Authors: WHEELER C SHULMAN LN ELIAS A AXELROD J SIEFF C CHURCHILL WH AYASH L GAYNES L MCCAULEY M THOMPSON L MAZANET R ANTMAN K TEPLER I SCHNIPPER L WEGNER S SCHWARTZ G ANTIN JH
Citation: C. Wheeler et al., SEQUENTIAL IFOSFAMIDE (I), CARBOPLATIN (C), AND ETOPOSIDE (E) WITH STEROIDS AND CYCLOPHOSPHAMIDE G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT (SPICE) IN RELAPSED LYMPHOMA/, Blood, 82(10), 1993, pp. 10000144-10000144
Risultati: 1-16 |